Are you thinking about taking part in a clinical trial? Read these five frequently asked questions about clinical trials.
“Delivering Discoveries: Expanding the Reach of Precision Medicine,” was the theme of the American Society of Clinical Oncology (ASCO) 2018 annual meeting held June 1-5, 2018 in Chicago. One of the largest scientific conferences in the world, the meeting brings together nearly 40,000 attendees and features thousands of studies about new ways to prevent, detect, and treat cancer.
It is patients like you, your loved ones, and Dr. Gertz's parents who keep us motivated and excited to find ways to help in the fight against this terrible disease. We appreciate everything you do as patients—like donating samples and participating in clinical trials—and we want you to know that we are doing everything we can to help patients with breast and uterine cancer.
John Karg was diagnosed with glioblastoma, a type of brain cancer, early in 2016. His cancer care team at Huntsman Cancer Institute treated the cancer with surgery, radiation, oral chemotherapy, and participation in clinical trials. He’s doing very well with the treatment—his interview for this article happened while he was waiting for the lift lines at Alta ski resort.
Finding trustworthy resources can be tricky. Here are some tips to help when you are looking for accurate information and reliable resources online.
HCI established The Society of Huntsman Translational Scholars to recognize excellence in the discipline of translational science. Deborah Stephens, DO, was recently honored with a Huntsman Translational Scholar award. She is the physician leader of the Hematology Clinical Trials at Huntsman Cancer Institute and is also an Assistant Professor in the Division of Hematology and Hematologic Malignancies at the University of Utah.
Alvin Kwok, MD, MPH, is a breast reconstruction surgeon who returned to Utah to join the Huntsman Cancer Institute team. He shares with us how breast reconstruction can help patients' outlook on their cancer journey. We also find out what delicious activities he's up to on his days off.
The conference aims to increase the understanding of cancer as a chronic disease and empower Hispanics/Latinos to increase their personal health and the health of their families and communities.
On May 16, 2018, HCI hosted a NASA astronaut and a team from the Center for the Advancement of Science in Space to discuss the opportunity of researching cancer in space.
HCI established The Society of Huntsman Translational Scholars to recognize excellence in the discipline of translational science. Theresa Werner, MD, was recently honored with a Huntsman Translational Scholar award. She is the medical director of Clinical Trials and treats patients with gynecologic cancers.
Huntsman Cancer Institute Opens Center for HOPE and is Awarded $9.7 Million to Improve Health Among Underserved Populations
Huntsman Cancer Institute (HCI) at the University of Utah (U of U) today announced the opening of the Cancer Population Sciences and Huntsman Center for Health Outcomes and Population Equity (HOPE), a new research and clinical space dedicated to preventing cancer and improving health among underserved populations and improving outcomes in cancer patients. The center recently received $9.7 million from the Patient-Centered Outcomes Research Institute (PCORI) to fund a clinical trial researching new and effective approaches to reduce tobacco use.
“Driving Innovative Cancer Science to Patient Care” was the theme of the American Association for Cancer Research (AACR) annual meeting, which took place April 14-18 in Chicago. Huntsman Cancer Institute (HCI) faculty and staff joined almost 22,000 other scientists, physicians, and patient advocates from around the world to share the latest findings in translational, clinical, and prevention-focused cancer research.
HCI established The Society of Huntsman Translational Scholars to recognize excellence in the discipline of translational science. Robert Andtbacka, MD, was recently honored with a Huntsman Translational Scholar award and will also lead the group for the coming year.
The Immortal Life of Henrietta Lacks is an acclaimed nonfiction book about the revolutionary research, ethical questions, and racism wrapped up in one woman’s cancer story.
When I was diagnosed with uterine sarcoma, behind all of the distress about treatment was an overwhelming feeling of disbelief that I was about to become infertile at age 28. But being able to retrieve and freeze my eggs before chemotherapy gave me back a little bit of the control I felt was lacking.
“Our perspective was to enjoy life no matter the circumstances. You find joy. Sometimes you have to search under the rug and in the closet, but there’s something to be happy about every day.”
The PathMaker Cancer Research Program is for high school and undergraduate students with backgrounds underrepresented in the biomedical workforce. Under the mentorship of an HCI scientist, PathMaker scholars conduct research and build a foundation for careers in health professions and biomedical research.
The POWER Program (Personal Optimism with Exercise Recovery) gives a personalized exercise plan for cancer patients based on diagnosis, treatment type and phase, and fitness goals. For Farley Eskelson, it also gave him the chance to get back to the activities he loves.
Patient groups learn from trained facilitators to reduce stress and pain, restore well-being, and feel calm and relaxed.
The Young Adult Cancer Caregiver study is currently recruiting participants. The study will look at how social media may help or hinder young adults who take care of a cancer patient.